Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Receivables - Net: 2017-2025

Historic Receivables - Net for Assembly Biosciences (ASMB) over the last 7 years, with Sep 2025 value amounting to $912,000.

  • Assembly Biosciences' Receivables - Net was N/A to $912,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $912,000, marking a year-over-year change of. This contributed to the annual value of $43,000 for FY2023, which is 95.44% down from last year.
  • Latest data reveals that Assembly Biosciences reported Receivables - Net of $912,000 as of Q3 2025, which was up 2,020.93% from $43,000 recorded in Q1 2024.
  • Assembly Biosciences' 5-year Receivables - Net high stood at $1.2 million for Q3 2022, and its period low was $43,000 during Q4 2023.
  • For the 3-year period, Assembly Biosciences' Receivables - Net averaged around $411,400, with its median value being $342,000 (2023).
  • Its Receivables - Net has fluctuated over the past 5 years, first skyrocketed by 180.95% in 2022, then tumbled by 95.44% in 2023.
  • Over the past 5 years, Assembly Biosciences' Receivables - Net (Quarterly) stood at $336,000 in 2021, then skyrocketed by 180.95% to $944,000 in 2022, then crashed by 95.44% to $43,000 in 2023, then plummeted by 94.00% to $43,000 in 2024, then reached $912,000 in 2025.
  • Its last three reported values are $912,000 in Q3 2025, $43,000 for Q1 2024, and $43,000 during Q4 2023.